Darling (DAR) Q1 2026 Earnings Call Transcript

Darling Ingredients reported Q1 2026 combined adjusted EBITDA of $407 million, up sharply from $196 million a year ago, with net sales rising to $1.6 billion and gross margin expanding to 26.1%. Management guided Q2 core ingredients EBITDA to $260 million-$275 million and said DGD should run near max capacity at 320 million gallons, with the new RVO and stronger feedstock/fuel markets supporting higher earnings through 2026. Net income swung to $134 million from a $26 million loss, while leverage was 3.17x and debt remains on track to fall below $3 billion.

Analysis

DAR is moving from an earnings-recovery story to a policy-and-spread capture story. The important second-order effect is that tighter RVO enforcement doesn’t just lift DGD economics; it propagates backward into the entire fat/protein value chain, forcing higher realized values for rendering outputs and narrowing the gap between commodity byproducts and premium channels. That should disproportionately benefit the integrated players with logistics, pretreatment, and international routing flexibility, while smaller biodiesel operators that lack working capital or credit monetization access may stay offline longer, effectively raising the industry clearing margin.

The market may be underestimating how much of the next leg is operational, not purely macro. Management is signaling that prior acquisitions are now yielding real routing and product-mix leverage, which means incremental feedstock inflation can actually expand EBITDA if the company keeps moving higher-value material into collagen, specialty proteins, and fuel pathways. That creates a convexity effect: each additional dollar of fat price can be a tailwind for DAR’s supply chain optimization rather than a simple cost headwind, especially over the next 1-2 quarters as price resets flow through.

The main risk is that current results are flattered by a non-recurring accounting benefit and by a very favorable transition phase in renewable fuels. Once the inventory benefit is gone, investors will have to underwrite the underlying run-rate with less optical support, and the stock could wobble if Q2 shows any lag from March to April feedstock repricing. Longer term, the bigger overhang is policy slippage or a sharp commodity reversal that compresses spreads before leverage gets meaningfully below $3B.

Key Decisions for Investors

• Long DAR into the May 11 Investor Day; use any post-call pullback to build a 3-6 month position. Risk/reward favors upside if management confirms leverage decline and Q2 guidance proves conservative.
• Pair trade: long DAR / short a weaker biodiesel or renewable diesel name with less feedstock flexibility and higher leverage. Thesis is that DAR captures the margin uplift while lower-quality operators remain constrained by working capital and feedstock access.
• Buy short-dated DAR calls or call spreads for the next 1-2 quarters if you want convexity to a Q2/Q3 guidance beat; the catalyst is margin flow-through from higher fat prices and RVO-driven demand.
• If DAR trades materially above the implied post-LCM run-rate without confirmation of debt reduction, trim 20-30% and re-enter on evidence of organic EBITDA growth. The optical quarter may overstate sustainable earnings.
• Watch for relative strength versus conventional energy and ag inputs over the next 30-60 days; if fat/protein pricing keeps rising, DAR should outperform processors and animal byproduct peers because it has the best end-market optionality.